1. To describe the progression of heart failure in metabolic terms.

2. Evaluate treatments for diabetes in heart failure in the context of heart failure stages.

3. Become familiar with CV outcomes observed in recent trials of therapies for Type-2 Diabetes.


Session date: 
Friday, March 24, 2017 - 12:00pm to 1:00pm
UCMC W-632
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Kenneth B. Margulies, M.D.